Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mechanically Engineered Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes (ME-UCMSC-Exo) are an exosome-based therapeutic derived from umbilical cord mesenchymal stem cells. These exosomes are mechanically engineered to enhance their therapeutic efficacy. They function by delivering bioactive molecules, including proteins, microRNAs, and growth factors, to target cells, thereby promoting tissue regeneration. This therapy is being investigated for its potential to improve endometrial thickness in women with thin endometrium, a condition linked to female infertility and intrauterine adhesions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Mechanically Engineered Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes.